@CardioOncology @BalkoLab @VUMC_Cancer @VUMCHemOnc @VUMChealth #Myocarditis #CardioOnc #CancerImmunotherapy #Cancer #Research A genetic mouse model recapitulates immune checkpoint inhibit…

Javid Moslehi, MD and Justin M. Balko, Pharm.D., Ph.D. from Vanderbilt-Ingram Cancer Center discuss A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention.InstractCancer therapy has been transformed by immune control point inhibitors (ICI) targeting CTLA-4 or PD-1/PD-L1 but is associated with immune-related…

Read the full article here

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: cancer, CancerImmunotherapy, CardioOnc, myocarditis, research

Tweets with this article

Oncology Tube

A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis @CardioOncology @BalkoLab @VUMC_Cancer @VUMCHemOnc @VUMChealth #Myocarditis #CardioOnc #CancerImmunotherapy #Cancer #Research Link To FULL Video: https://t.co/bh6LaGuau5... https://t.co/1r1Tn0G8Vm

Related Articles

Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD

Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the…

Oncology Tube April 18, 2024

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent…

Oncology Tube April 18, 2024

Scott Kopetz, MD – KRYSTAL-1: Adagrasib-Cetuximab for KRASG12C CRC

Dr. Scott Kopetz discussed the KRYSTAL-1 study at AACR, presenting promising results of combining adagrasib and cetuximab to target KRASG12C mutated colorectal cancer, reporting a…

Oncology Tube April 10, 2024

Ajay Goel, PhD – Exosome Biopsy Detects Pancreatic Cancer

Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a…

Oncology Tube April 10, 2024

Ajay Goel, PhD – Exosome Biopsy Detects Pancreatic Cancer

Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a…

Oncology Tube April 10, 2024

Revolutionizing Pancreatic Cancer Detection: The Groundbreaking Role of Liquid Biopsies – Ajay Goel, PhD [AACR 2024]

Uncover a revolutionary approach to pancreatic cancer detection. Delve into the study’s methodology and learn how microRNAs are used in liquid biopsies for unparalleled accuracy.

Oncology Tube April 10, 2024

Targeting SCD1 in KRAS Mutant Non-Small Cell Lung Cancer: A Novel Therapeutic Strategy

Uncover the impact of SCD1 in NSCLC with concurrent KRAS, STK11, and KEAP1 mutations. Learn about the potential of SCD1 as a novel therapeutic target…

Oncology Tube April 8, 2024

Lenvosiltamab: A Groundbreaking Advance in Multiple Myeloma Treatment

Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.

Oncology Tube April 7, 2024

Lurbinectedin: Enhancing Immunotherapy Efficacy in Small Cell Lung Cancer

Find out how combining traditional chemotherapies with Lurbinectedin can improve outcomes in small cell lung cancer. Discover the therapeutic potential of this innovative treatment.

Oncology Tube April 7, 2024

Efficacy and Safety of Inotuzumab Ozogamicin – MOASC 2024

Mojtaba Akhtari, MD, FACP-Professor of Medicine-Loma Linda University explains the Efficacy and Safety of Inotuzumab Ozogamicin – from the MOASC 2024 Advances in Oncology meeting…

Oncology Tube March 10, 2024